CNBD1

Chr 8

cyclic nucleotide binding domain containing 1

This gene encodes a cyclic nucleotide-binding domain-containing protein that regulates cellular signaling pathways involving cyclic AMP and cyclic GMP. Mutations cause autosomal recessive cone-rod dystrophy, a progressive retinal degeneration that typically begins in childhood with decreased central vision and color discrimination deficits, followed by progressive loss of peripheral vision. The gene shows low constraint against loss-of-function variants, consistent with the recessive inheritance pattern observed in affected families.

0
Active trials
1
Pubs (1 yr)
33
P/LP submissions
0%
P/LP missense
1.70
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryCNBD1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
33 unique Pathogenic / Likely Pathogenic· 73 VUS of 129 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.70LOEUF
pLI 0.000
Z-score -0.92
OE 1.22 (0.881.70)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-1.33Z-score
OE missense 1.26 (1.141.40)
255 obs / 201.8 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE1.22 (0.881.70)
00.351.4
Missense OE1.26 (1.141.40)
00.61.4
Synonymous OE0.88
01.21.6
LoF obs/exp: 24 / 19.6Missense obs/exp: 255 / 201.8Syn Z: 0.80
DN
0.6452th %ile
GOF
0.73top 25%
LOF
0.3745th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

129 submitted variants in ClinVar

Classification Summary

Pathogenic33
VUS73
Likely Benign11
Conflicting1
33
Pathogenic
73
VUS
11
Likely Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
33
0
33
Likely Pathogenic
0
0
0
0
0
VUS
0
61
12
0
73
Likely Benign
0
6
4
1
11
Benign
0
0
0
0
0
Conflicting
1
Total067491118

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CNBD1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found